Room-temperature stable dronabinol formulations
US8628796B2 · kind B2 · utility
11Cited by
41References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2005 |
| Grant date | Jan 14, 2014 |
| Priority date | — |
| Expiry date | Jun 16, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A room temperature stable cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation is dronabinol in an oil-based carrier contained within a hard gelatin capsule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.